Singapore markets open in 4 hours 4 minutes

MedTech Acquisition Corporation (MTAC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.06-0.02 (-0.20%)
As of 02:01PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 314.18M
Enterprise value 315.61M
Trailing P/E 36.12
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.31
Enterprise value/revenue N/A
Enterprise value/EBITDA -124.66

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 31.16%
S&P500 52-week change 3-12.31%
52-week high 310.21
52-week low 38.99
50-day moving average 39.99
200-day moving average 39.89

Share statistics

Avg vol (3-month) 340.16k
Avg vol (10-day) 3122.95k
Shares outstanding 525M
Implied shares outstanding 6N/A
Float 825M
% held by insiders 10.00%
% held by institutions 197.44%
Shares short (14 Nov 2022) 45.3k
Short ratio (14 Nov 2022) 40.29
Short % of float (14 Nov 2022) 40.02%
Short % of shares outstanding (14 Nov 2022) 40.02%
Shares short (prior month 13 Oct 2022) 44.37k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)8.78M
Diluted EPS (ttm)0.28
Quarterly earnings growth (yoy)-64.60%

Balance sheet

Total cash (mrq)207.6k
Total cash per share (mrq)0.01
Total debt (mrq)1.64M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.16
Book value per share (mrq)-0.37

Cash flow statement

Operating cash flow (ttm)-2.15M
Levered free cash flow (ttm)N/A